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ABSTRACT
Tinnitus is a phantom sound perceived in the absence of external acoustic stimulation, which is only heard by the 
affected person. It is described in a variety of ways and can be a single sound or combination of different sounds. 
Tinnitus is related to many other conditions and has an impact in the quality of life of the affected person. However, 
pathophysiological mechanisms underlying tinnitus and their basic biological remains unknown. One of the major 
challenges, concerning the heterogeneity of the tinnitus condition, is the lack of standardization in research and 
clinical management. For this, the TINNET, a European Cost Action for research, has the main objective to develop 
better strategies for diagnosis and management. The establishment of guidelines for clinical diagnosis, treatment, 
neuroimaging assessments and outcome assessment, through the identification of clinically meaningful tinnitus 
subtypes, provides an important basis for the standardization of clinical research and management of tinnitus.
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SYMPTOMS, CAUSES AND 
GLOBAL BURDEN
Tinnitus derives from the latin word tinnire (to ring). 
Tinnitus is a symptom that comprises the perception 
of a sound in the ears or head, without a corresponding 
external acoustic stimulus. The percept can be a sim-
ple sound like hissing, sizzling and ringing, or a complex 
composite of sounds, or multiple separate sounds.1 Sin-
ce ancient times, we can find records reporting the con-
dition and its treatment. For example, an Egyptian me-
dical document originating in 2500 BC called the Ebers 
Papyrus refers to the ‘bewitched ear’ and recommends 
intra-aural infusions as a treatment.2,3 
Tinnitus can cause significant emotional reactions to it 
and negatively impact the quality of life of the affected 
person. Clinicians talk about habituation to tinnitus so 
that over time symptom severity tends to diminish.4 In-
deed, a systematic review that pooled outcomes for ‘no-
-intervention’ controls across a number of randomized 
controlled trials also confirmed a small but consistent re-
duction in symptom severity.5 Those individuals who do 
remain disturbed by their tinnitus over the longer term 
may be those with some additional comorbidity such as 
generalized anxiety, depression, hyperacusis, headache, 
and vertigo, which may make the individual more prone 
to focus attention on their tinnitus symptoms.6-10 
There are two broad categories of tinnitus; objective 
and subjective. Tinnitus can be objective when it is au-
dible by others, but these account for less than 1% of 
all cases. Objective tinnitus mainly originates from vas-
cular or muscular problems in the vicinity of the ear or 
in the head and neck.11,12 Tinnitus can be pulsatile and 
if it is synchronous with the heart beat then a vascular 
pathology might be suspected. In particular, when there 
is a unilateral pulsatile tinnitus that is synchronous with 
the heart beat then there is an 80% higher probability 
that the origin is a vascular loop adjacent to the VIIIth 
cranial nerve.13 
In the majority of cases, tinnitus is subjective because 
it is audible only by the person affected. Subjective tin-
nitus can be associated with a variety of medical condi-
tions, both otological and non-otological.14-16 For exam-
ple, a low frequency tinnitus is most typical of Ménière’s 
disease.17 However, nearly 30% of all tinnitus cases are 
considered to be idiopathic.14-16 Tinnitus etiology can be 
multifactorial and complex, and given its often gradual 
onset, even careful medical history taking cannot always 
identify a cause.
Epidemiological case control studies confirm hearing 
loss and ageing,18 noise exposure19-21 exposure to oto-
toxic medication22,23 and depression24 as some of the 
most common risk factors. Nearly 40% of people with 
tinnitus are also reported to experience some degree of 
sound tolerance (hyperacusis),25 but whether there is a 
pathophysiological link between these two conditions 
remains unknown. Other known associations include 
sleeping problems,26-28 head or neck injury29 and emo-
tional exhaustion.30 For some authors tinnitus is regar-
ded as the result of chronic stress and related immune 
response.31
With respect to hearing loss, associations are more than 
simply having both conditions. When a hearing loss is 
present, the tinnitus frequency usually matches the re-
gion of greatest threshold losses, especially in the case 
of down-sloping sensorineural hearing loss profiles.32 
Nevertheless, not everyone with a hearing loss has tin-
nitus, and some people with tinnitus have a normal clini-
cal audiometric profile.
RESUMO
O acufeno consiste numa perceção sonora na ausência de correspondente estimulação acústica externa, que é apenas ouvi-
do pela pessoa afetada. É descrito de várias formas e pode ser um som único ou uma combinação de diferentes sons. O acu-
feno está relacionado a outras condições e tem impacto na qualidade de vida da pessoa afetada. No entanto, os mecanismos 
fisiopatológicos subjacentes ao acufeno e as suas características biológicas básicas permanecem desconhecidos. Um dos 
maiores desafios, devido à heterogeneidade subjacente ao acufeno, é a falta de padronização na pesquisa e no tratamento 
clínico. Para isso, a TINNET uma rede de investigação europeia, tem como principal objetivo desenvolver melhores estraté-
gias de diagnóstico e tratamento. A criação de diretrizes para o diagnóstico clínico, tratamento, avaliações de neuroimagem 
e avaliação de resultados, através da identificação de subtipos do acufeno clinicamente relevantes, fornecem uma base im-
portante para futuras meta-análises e otimização da terapêutica do acufeno.
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It is widely posited that if prognostic indicators and cli-
nically meaningful subtypes or profiles of tinnitus could 
be identified then this would be an effective approach 
to reducing the variable responsiveness to the different 
management options currently available. However, pa-
thophysiological mechanisms underlying tinnitus are so 
far elusive and so, without this basic biological unders-
tanding and the identification of tinnitus biomarkers, 
these goals have not yet been achieved.
It is estimated that one in ten people have tinnitus, and 
so the global burden of tinnitus is very high.33 Informa-
tion about the prevalence of tinnitus is rather patchy. 
A recent systematic review of adults (aged 18 years or 
more) found that global prevalence ranged from 1.5% 
to 42.7%.34 But many of these studies defined tinnitus in 
slightly different ways and so this may explain the wide 
range. For those population-based studies which used 
the same tinnitus definition, prevalence rate was some-
what narrower (11.9% to 30.3%). Examining the study 
information indicated that prevalence increased with 
age, and was also slightly higher for men than for wo-
men, but this may be explained by occupational rather 
than biological differences between the sexes. 
A large American cross-sectional study found that 21.4 
million people have tinnitus, and of those 36% expe-
rience constant tinnitus, 15% experienced tinnitus at 
least once every day and 49% at least once a week.33 
Concerning tinnitus symptom severity, 7.2% described 
their condition as a ‘big or very big problem’, 20.2% as 
a ‘moderate problem’, and 72.6% as ‘not a bothersome 
problem’.33 The Tinnitus Functional Index35 is an instru-
ment that can be used as a diagnostic tool to grade ove-
rall symptom severity and this has five category levels 
from ‘very big problem’ to ‘not a problem’.
Results from the most recent World Health Organiza-
tion (WHO) Global Burden of Diseases (2015) reports 
hearing loss as the fourth leading cause of years lived 
with disability. Given the strong links between hearing 
loss and tinnitus, then tinnitus surely follows this trend. 
It has been recognized that the economic burden to so-
ciety is high compared to some other chronic conditions. 
For example, a large prospective Swedish cohort study 
found that sickness absence at work due to tinnitus 
and hearing loss increased the risk of future claims for 
disability pension by three times compared to non-au-
diological diagnoses.36 Furthermore, tinnitus is the most 
common complaint in modern warfare. For example, the 
annual disability compensation paid by US department 
of Veteran’s Affairs for tinnitus and hearing loss exceeds 
$2 billion USD.37
NEED FOR STANDARDIZATION
Many people with tinnitus do not seek medical support. 
Even for those reporting tinnitus as a bothersome pro-
blem, the American survey described earlier found 
that only 50% had visited a physician for a consultation 
appointment.33 Although there are multiple manage-
ment options for tinnitus, the majority lack high quality 
scientific evidence to support strong claims for their 
benefit. Perhaps of all therapeutic options, cognitive 
behavioral therapy (CBT) delivered by a qualified clinical 
psychologist has the most support for its effectiveness 
in reducing tinnitus symptom severity.38-40
Given the heterogeneity of the tinnitus condition, one 
of the major challenges to advancing the field of tinnitus 
concerns the lack of standardization in approaches to re-
search and clinical management. To address this, a Euro-
pean consortium gathered together in 2014 under the 
auspices of a four-year European Cost Action BM1306 
“Tinnitus Research Network” (TINNET) (http://tinnet.
tinnitusreserch.net/). The main objective of this Action 
was the creation of an international network for identi-
fying clinically meaningful subtypes of tinnitus and their 
neurobiological underpinnings in order to develop bet-
ter strategies for diagnosis and management. TINNET 
comprised five working groups (WG) covering clinical, 
database, neuroimaging, genetics and measurement 
outcomes. These coordinated efforts from basic scien-
tists, technicians and clinicians working in different me-
dical disciplines working together in close collaboration. 
A set of ambitious interdisciplinary objectives were to 
create standards for identifying: i) meaningful clinical 
and demographic characteristics for tinnitus subtyping 
(WG1), ii) assessing tinnitus-related changes in brain 
activity associated with different subtypes of tinnitus 
(WG3), iii) intermediate genetic phenotypes and genetic 
factors in the pathogenesis of tinnitus (WG4), iv) stan-
dards for assessing outcomes after clinical intervention 
(WG5). Cross-cutting all of these themes WG2 was ai-
med at establishing an electronic data repository to pro-
mote scientific transparency and support data sharing.
The legacy from TINNET is wide ranging. WG1 have ga-
ther the opinions of clinical experts using consultation 
methods to generate an evidence-based good practice 
guideline for the assessment and management of people 
with bothersome tinnitus. This is now in the final stage of 
dissemination but was launched at the 11th Tinnitus Re-
search initiative and 2nd TINNET conference in Regens-
burg in March 2018. WG3 has established a consensus 
for neuroimaging data acquisition based on input from 
tinnitus experts in neuroimaging from across the world. 
Recommendations for electroencephalography (EEG) 
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and magnetoencephalography (MEG) are already avai-
lable on the TINNET website. The recommendations for 
magnetic resonance imaging (MRI) are in the final sta-
ges of dissemination. WG4 have published an updating 
study exposing that the available evidence for genetics 
in tinnitus is scarce and addressing the ideal design of 
studies concerning tinnitus genetic should use concor-
dance twin studies and optimize patient selection accor-
ding to phenotype and/or etiology to avoid genetic in-
terpretation bias.41 WG5 have gathered the opinions of 
many different stakeholders including people with tin-
nitus as well as professionals using consensus methods 
to produce recommendations for what tinnitus-related 
complaints are critical and important to measure when 
assessing treatment-related benefit. Of interest, these 
guidelines separately consider sound-based, psycholo-
gy-based and pharmacology-based interventions, since 
each of these approaches has a different therapeutic ra-
tionale and therefore aims to address different tinnitus 
symptoms. For WG5, a series of publications has alrea-
dy appeared in various peer-reviewed journals42-45 and 
the main findings are again in the final stage of dissemi-
nation. The next step is to identify how the different tin-
nitus-related complaints should be measured. This work 
will continue over the next few years beyond the initial 
TINNET funding.
CONCLUDING REMARKS
TINNET has been an important pan-European project in 
bringing together a range of multi-disciplinary experts 
with an interest in tinnitus. The four years have succee-
ded in generating a tinnitus community. While the gui-
delines thus created for clinical diagnosis, management, 
neuroimaging assessments and outcome measurements 
provide an important basis for standardization, the futu-
re challenge will be in ensuring that these recommenda-
tions are adopted and implemented on an international 
scale. Only by working together as a community can we 
ultimately pave the way to help our patients more effec-
tively manage their symptoms and ultimately to find a 
cure for this debilitating condition.
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